Shift Pharmaceuticals
PrivateLast Round
Grant
Jul 24, 2018
Total Funding Raised
$3M
Company Overview
Shift Pharmaceuticals is a biotechnology company that develops antisense oligonucleotide-based therapeutics for the treatment of neuromuscular and genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shift Pharmaceuticals Comparables
Compare Shift Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Armatus Bio | 87% | |
| SQY Therapeutics | 79% | |
| Nervosave Therapeutics | 78% | |
Shift Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 24, 2018 |
Shift Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Congressionally Directed Medical Research Programs | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2025
Monthly visitors increased 1083% MoM, reaching 1.1K.
- Jul 24, 2018
$3M grant from Congressionally Directed Medical Research Programs and NIH.
Shift Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shift Pharmaceuticals's valuation, stock price, and market status.